Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative PCA after thoracic surgery
ChiCTR2500114767Phase 4Not yet recruiting
- Sponsor
- Enze Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain and None (2 arms), sponsored by Enze Hospital. Primary endpoints: QoR-15 score at 24 hours after surgery and QoR-15 score at 48 hours after surgery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500114767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114767.